+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sarcoma Drug"

Soft Tissue Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Ewing Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Ewing Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 115 Pages
  • Global
From
Kaposi's sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Kaposi's sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Synovial Sarcoma Pipeline Analysis Report - Product Thumbnail Image

Synovial Sarcoma Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
Soft Tissue Sarcoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Soft Tissue Sarcoma Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
Ewing Sarcoma - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Ewing Sarcoma - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 352 Pages
  • Global
From
Soft Tissue Sarcoma: Competitive Landscape - Product Thumbnail Image

Soft Tissue Sarcoma: Competitive Landscape

  • Report
  • June 2024
  • 79 Pages
  • Global
From
Global Oncolytic Virus Therapy Market Outlook to 2035 - Product Thumbnail Image

Global Oncolytic Virus Therapy Market Outlook to 2035

  • Report
  • April 2023
  • 144 Pages
  • Global
From
Protein Kinase C Theta Type - Pipeline Review, H2 2020 - Product Thumbnail Image

Protein Kinase C Theta Type - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 33 Pages
  • Global
From
Clear cell sarcoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Clear cell sarcoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Epithelioid Sarcoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Epithelioid Sarcoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Ewing Sarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Ewing Sarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Kaposi's Sarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Kaposi's Sarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Synovial Sarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Synovial Sarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

Sarcoma is a type of cancer that affects the connective tissues of the body, such as muscle, bone, fat, and blood vessels. Sarcoma drugs are used to treat this type of cancer, and are part of the larger oncology drug market. These drugs are typically used in combination with other treatments, such as surgery, radiation, and chemotherapy. Sarcoma drugs are designed to target the specific type of cancer, and can be used to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of metastasis. The sarcoma drug market is highly competitive, with many companies developing new treatments and therapies. Some of the major players in the market include Pfizer, Merck, Novartis, Bristol-Myers Squibb, and Eli Lilly. Other companies, such as Amgen, AstraZeneca, and Celgene, are also developing treatments for sarcoma. Show Less Read more